Topic: Bat Lab

New reports indicate that a top FDA official admitted to a congressional committee that the government did not sufficiently inform the public about vaccine deaths. Additionally, Colorado State University is allegedly developing a "tier one" bat lab to research agents like Ebola. The host also claims that major blood companies are beginning to screen for vaccinated blood.

A bat biologist recounts an "awakening" regarding the origins of COVID-19 after a Twitter follower pointed out the proximity of the Wuhan biosafety lab to the initial outbreak. Initial support for masks and official narratives shifted as new data emerged, illustrating the scientific process of model improvement. The importance of admitting errors and adjusting to evidence is emphasized as a key trait for credible analysts.

Dr. Richard Bartlett returns to discuss the technical details of the Ervebo Ebola vaccine, noting its 31.7% shedding rate according to FDA inserts. He expresses concern over the construction of a new "Wuhan-style" bat research lab in Fort Collins, Colorado. Bartlett questions why Denver health officials are preparing for an Ebola outbreak now, suggesting they may have prior knowledge of potential risks.

Denver Health medical teams have received a live Ebola vaccine produced by Merck, despite no active outbreaks in the region. This coincides with the construction of a new bat research lab in Fort Collins, Colorado, which is reportedly funded to study high-consequence pathogens. FDA documents for the Ervebo vaccine confirm a significant shedding rate, raising concerns about secondary infections in the community.

DARPA documents cited by Tom Renz suggest that COVID-19 may have escaped from a lab as early as August 2019 in an "attenuated vaccine form." Renz discusses the development of aerosolized vaccines designed to be sprayed in bat caves, comparing this to the "shedding" phenomenon reported with mRNA vaccines. He argues that the distinction between the virus and the vaccine is increasingly blurred.